Intensity Therapeutics, Inc.
INTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $24 | $74 | $78 | $78 |
| - Cash | $3 | $9 | $1 | $5 |
| + Debt | $0 | $0 | $4 | $2 |
| Enterprise Value | $22 | $65 | $81 | $76 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$16 | -$10 | -$8 | -$8 |
| % Margin | – | – | – | – |
| Net Income | -$16 | -$11 | -$8 | -$8 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.17 | -0.87 | -0.58 | -0.6 |
| % Growth | -34.5% | -50% | 3.3% | – |
| Operating Cash Flow | -$15 | -$7 | -$5 | -$7 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$15 | -$7 | -$5 | -$7 |